Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Anti-dsDNA IgG ELISA Kit

Human ELISA Kit Colorimetric assay for quantification of Human and has been mentioned in 1 publication.
Catalog No. ABIN1326829

Quick Overview for Anti-dsDNA IgG ELISA Kit (ABIN1326829)

Target

Anti-dsDNA IgG

Reactivity

Human

Detection Method

Colorimetric

Method Type

Competition ELISA

Application

ELISA

Sample Type

Serum
  • Purpose

    Diluted patient serum is added to wells coated with purified dsDNA antigen. Specific antibody, if present, binds to the antigen. All unbound materials are washed away and the enzyme conjugate is added to bind to the antibody-antigen complex, if present. Excess enzyme conjugate is washed off and substrate is added. The plate is incubated to allow the hydrolysis of the substrate by the enzyme. The intensity of the color generated is proportional to the amount of specific antibody in the sample.

    Analytical Method

    Qualitative
  • Plate

    Pre-coated

    Restrictions

    For Research Use only
  • Storage

    4 °C
  • Rupasree, Naushad, Rajasekhar, Uma, Kutala: "Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF-? promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians." in: Lupus, Vol. 24, Issue 1, pp. 50-7, (2014) (PubMed).

  • Target

    Anti-dsDNA IgG

    Target Type

    Antibody

    Background

    Anti-dsDNA is present in 50 % to 70% of patients with systemic lupus erythematosus (SLE). Circulating DNAanti-DNA immune complexes are considered to play a part in the pathogenesis of SLE. The presence of anti-dsDNA is one of the diagnostic criteria for SLE. IgG antibodies to dsDNA are considered clinically most useful for the diagnosis and management of SLE. Antibodies to single stranded DNA (ssDNA) and IgM antibodies to DNA are found in a number of other connective diseases, liver diseases, as well as in some normal iniduals. ELISA is the method of choice for the screening of anti-dsDNA in-patients with suspected SLE.
You are here:
Chat with us!